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Abstract
Background: Comorbidity complicates estimations of health-adjusted life expectancy (HALE)
using disease prevalences and disability weights from Burden of Disease studies. Usually, the exact
amount of comorbidity is unknown and no disability weights are defined for comorbidity.
Methods: Using data of the Dutch national burden of disease study, the effects of different
methods to adjust for comorbidity on HALE calculations are estimated. The default multiplicative
adjustment method to define disability weights for comorbidity is compared to HALE estimates
without adjustment for comorbidity and to HALE estimates in which the amount of disability in
patients with multiple diseases is solely determined by the disease that leads to most disability (the
maximum adjustment method). To estimate the amount of comorbidity, independence between
diseases is assumed.
Results: Compared to the multiplicative adjustment method, the maximum adjustment method
lowers HALE estimates by 1.2 years for males and 1.9 years for females. Compared to no
adjustment, a multiplicative adjustment lowers HALE estimates by 1.0 years for males and 1.4 years
for females.
Conclusion: The differences in HALE caused by the different adjustment methods demonstrate
that adjusting for comorbidity in HALE calculations is an important topic that needs more attention.
More empirical research is needed to develop a more general theory as to how comorbidity
influences disability.
Background
Health-adjusted life expectancy (HALE) is a summary
measure of population health that has been introduced as
part of the Health Expectancy Network (Réseau Espérance
de Vie en Santé, or REVES) and is defined as: "a generic
term for a weighted expectation of life summed over a complete
set of health states" [1]. HALE, like life expectancy, is inde-
pendent of the size and composition of the population
and is therefore useful to make comparisons between
populations and over time [2]. One method of estimating
HALE is by using data available from Burden of Disease
studies [3]. As a first step to estimate HALE from Burden
of Disease data, disease prevalences are coupled to disease
specific disability weights to estimate the average amount
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of disability in a population specified by sex and age [4].
Disability weights reflect the relative severity and impact
of a disease and theoretically range from 0 (no disability)
to 1 (death) [5]. Then, the average amount of disability
can be combined with a life table to estimate HALE. In
this paper, we will focus on this specific form of HALE that
has also been termed disability-adjusted life expectancy
(DALE) [3,4].
Comorbidity, defined as the presence of two or more dis-
eases in one person, complicates HALE calculations for
two reasons. The first one is that the exact amount of
comorbidity is unknown since all data on disease inci-
dence, prevalence and mortality gathered in Burden of
Disease (BOD) studies are disease specific [6]. The second
reason is that there are no disability weights defined for
comorbidity [6]. In a previous study, Barendregt and Bon-
neux found that HALE was generally insensitive to differ-
ent methods to define disability weights for comorbidity
[7]. However, they limited their research to six diseases
and to comorbidity between disease pairs only. In this
article, we will examine the impact of different methods to
define disability weights for comorbidity on HALE esti-
mates and compare them with HALE estimations without
adjustment for comorbidity.
If burden of disease data and disability weights are used
for calculations of HALE, disability weights for comorbid-
ity are usually calculated assuming a multiplicative model
[4,8]. The multiplicative model implies that disability
increases with the number of conditions one has, but that
the overall effect is less than additive. This is in line with
findings of Verbrugge et al. [9]. They tested whether disa-
bility increased linearly with the number of chronic con-
ditions individuals have and investigated whether there
are interaction effects on disability for specific combina-
tions of chronic diseases. They concluded that although
disability increases as the number of chronic conditions
increases, the marginal increase decreased as the number
of conditions increases. However, they also found that in
many cases the disability caused by having two diseases
was not higher than having either one of the two diseases.
This latter finding suggests that solely the disease that
leads to most disability determines the total amount of
disability in patients with multiple diseases. To investigate
the effect of adjustments for comorbidity we estimated
HALE using two different methods to define disability
weights for comorbidity:
- multiplicative adjustment method: using this method it
is assumed that the impact on disability due to comorbid-
ity is proportional. Although disability increases with
additional diseases, it is less than the sum of disability
weights for the individual diseases. This is the default
method used in HALE calculations [4,8];
- maximum adjustment method: using this method the
disability weight for comorbidity equals the disability
weight of the disease with the highest disability weight.
This adjustment for comorbidity can be thought of as a
maximum adjustment since having multiple diseases only
leads to more disability if individual diseases lead to more
disability. The total amount of disability attributed to
comorbidity is equal to the highest amount of disability
associated with one of the concurrent diseases.
To quantify the importance of comorbidity adjustments,
we will use HALE estimates without adjustments for
comorbidity as a comparator. In the next section, we
describe how to estimate the average disability weight and
HALE using the different adjustment methods if inde-
pendence between diseases is assumed. Then, results of
HALE estimates are presented. In the last section, implica-
tions of the results and directions for future research are
discussed.
Methods
In order to estimate HALE we set up an abridged life table
using mortality rates for the Netherlands from 1999 [10].
The number of life years obtained from the life table were
multiplied by one minus the average disability weights:
HALEg,a, health-adjusted life expectancy gender g age a
Lg,a number of life years lived between age a and a+5 for gender
g
Lg,85+ number of life years lived after age 85 for gender g
mg,a average disability weight between age a and a+5 for gender
g
mg,85+ average disability weight after age 85+ for gender g
lg,a number of survivors at age a in the life table cohort for gen-
der g
z last open-ended age interval in the life table
Age and sex specific average disability weights are a func-
tion of disease specific prevalence rates and disability
weights. In our study, data from the Dutch Burden of Dis-
ease Study was used to estimate average disability weights.
The Dutch Burden of Disease Study estimated disability
weights, using a large panel of experts and the person
trade off method [11], and disease prevalence of 48 differ-
ent disease categories [12]. All data used in our calcula-
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tions (mortality rates, disease prevalences and disability
weights) are available in Additional file 1.
To estimate comorbidity prevalence, independence
between diseases is assumed so the amount of comorbid-
ity between disease 1 and 2 (the joint prevalence of dis-
eases 1 and 2) is simply the product of their prevalence
rates:
p(1,2) joint prevalence of disease 1 and 2
p(d) joint prevalence of d diseases
Gender-specific average disability weights were calculated
using age classes of five years (0–4, 5–9, 10–14 to 85+).
However, for notational simplicity, age and sex indices
have been omitted in the notation.
No adjustment for comorbidity
When no adjustment for comorbidity is made the average
disability weight can be calculated by simply adding up
the disability caused by all diseases:
m average disability weight
pd prevalence rate of disease d
wd disability weight of disease d
Making no adjustment for comorbidity is equivalent to
assuming that effects of comorbidity on disability are
additive. Thus, if a person has more than one disease his
total disability weight equals the sum of the disability
weights for those diseases. However, in this interpretation
individual disability weights may add up to more than
one. This cannot be interpreted in a plausible way because
it would imply that more than one year of health is lost
when living for one year with those diseases.
Multiplicative adjustment method
Using this method, it is assumed that the increase in disa-
bility due to comorbidity disability is proportional. Total
disability for an individual having more diseases can be
written as:
w(1,2) disability weight of an individual with disease 1 and 2
w(d) disability weight of an individual with d diseases
This implies that the disability due to comorbidity
increases with more comorbid diseases but is less than the
sum of individual disability weights for all comorbid dis-
eases. If there are only 2 diseases the average disability
weight assuming independence equals:
m = 1 - (1 - p1) (1 - p2) + (1 - p2) p1 (1 - w1) + (1 - p1) p2 (1
- w2) + p1p2 (1 - w1) (1 - w2) = 1 - (1 - p1w1) (1 - p2w2)   (5)
This can be generalized to d diseases:
Maximum adjustment method
Compared to having one disease, having two diseases
only leads to more disability if the second disease causes
more disability than the first one. Assuming that the dis-
eases are ordered in terms of disability weights, e.g.
w1≥w2≥w3............wn someone who has disease 1 and 2 has
a disability weight that equals that of w1 since disease 1 is
worse than disease 2:
In order to estimate average disability weights using this
method the prevalence rate for which disease d has the
highest disability weight must be estimated (denoted Hd).
We can recursively define the prevalence rate Hd  (see
Appendix for a derivation):
Hd prevalence rate for which disease d has the highest disability
weight
The average disability weight can then be written as:
Comparing different methods to adjust for comorbidity
Compared to no adjustment, the multiplicative adjust-
ment method results in a lower average disability weight
but compared to the maximum adjustment method in a
higher average disability weight:
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For d diseases:
Results
Figures 1 and 2 display the estimated average disability
weights for men and women, using the different adjust-
ment methods.
By definition, the maximum adjustment method results
in the lowest estimate of the average disability weight and
no adjustment for comorbidity in the highest estimate.
The difference between the adjustment methods increases
with age. This is caused by the higher amount of comor-
bidity in the elderly. At age 85 and over the difference in
the average disability weight between the multiplicative
adjustment method and no adjustment amounts to 0.11
for men and 0.14 for women. The difference between the
multiplicative and maximum adjustment methods are
0.11 and 0.13 for respectively men and women aged 85
and over. Thus, the choice for adjustment method has
more implications in an elderly population than in a
younger population.
Tables 1 and 2 display estimates of life expectancy and
HALE. Life expectancy for Dutch males in 1999 was 75.9
years. Depending on the adjustment method for comor-
bidity, 65.7 to 67.9 years are considered healthy years.
Females have a higher life-expectancy, and also a higher
HALE. Independent of the method of adjustment,
women's HALE, relative to life expectancy, is always lower
than men's HALE. This reflects the fact that men more
often than women die from lethal diseases with a short
duration (e.g. lung cancer). At birth, the difference in
HALE between the multiplicative and maximum adjust-
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Table 1: Life Expectancy (LE) and Health-adjusted Life 
Expectancy (HALE) for Dutch males, 1999
Age LE HALE
No adjustment Multiplicative 
adjustment method
Maximum 
adjustment method
0 75.9 65.7 66.7 67.9
15 61.5 51.7 52.6 53.8
60 19.4 13.5 14.4 15.4
Average disability weights for men in the Netherlands 1999 using different methods to adjust for comorbidity Figure 1
Average disability weights for men in the Netherlands 1999 using different methods to adjust for comorbidity.
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ment method is 1.2 years for males and 1.9 years for
females. For males, the difference in HALE between the
multiplicative and maximum adjustment method
declines from 1.2 years at birth to 1.0 at the age of 60. For
females, the differences between the methods are some-
what larger. The difference of 1.9 years in HALE at birth
between the multiplicative and maximum adjustment
method declines to 1.6 at the age of 60. For both males
and females at all ages, the differences between no adjust-
ment and multiplicative adjustment are smaller than the
differences between the multiplicative and maximum
adjustment method.
Discussion and conclusion
In this study, two different methods to adjust for comor-
bidity in HALE calculations were compared to HALE esti-
mates without adjustment for comorbidity. The methods
differ in the manner in which disability weights for
comorbid conditions were defined. The multiplicative
adjustment method implies that comorbidity increases
disability but that the effects are less than the sum of dis-
ability from the individual diseases. Using the maximum
adjustment method, disability is solely determined by the
most severe disease. Compared to no adjustment, a mul-
tiplicative adjustment lowers HALE estimates with 1.0
years for males and 1.4 years for females. The maximum
adjustment methods lowers HALE estimates compared to
the multiplicative adjustment with 1.2 years for males and
1.9 years for females. Thus, the differences in HALE result-
ing of differences in defining disability weights are larger
than the differences between no adjustment and the mul-
tiplicative adjustment method. Although we think the dif-
ferences in HALE resulting of the different methods to
define disability weights are important, also uncertainly
related to the estimation of the prevalence of each of the
48 diseases may cause substantial variations in the average
disability weights and, therefore, on HALE estimates.
However, it is difficult to quantify this uncertainty
because uncertainty estimates around the disease preva-
Table 2: Life Expectancy (LE) and Health-adjusted Life 
Expectancy (HALE) for Dutch females, 1999
Age LE HALE
No adjustment Multiplicative 
adjustment method
Maximum 
adjustment method
0 81.0 68.5 69.9 71.8
15 66.6 54.4 55.8 57.6
60 23.8 15.8 17.1 18.7
Average disability weights for women in the Netherlands 1999 using different methods to adjust for comorbidity Figure 2
Average disability weights for women in the Netherlands 1999 using different methods to adjust for comorbidity.
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lence are not available [12]. In an attempt to test the sen-
sitivity of HALE for variations in prevalence rates we
calculated HALE using the multiplicative adjustment
method and increased all prevalence rates with 10%. This
lowered HALE estimates with less than one year for both
males and females.
Contrary to our results, Barendregt and Bonneux found in
a previous study that HALE was generally insensitive to
different methods of weighing comorbidity [7]. However,
they limited themselves to six diseases and to comorbidity
between disease pairs only. In our study, all possible com-
binations of comorbidity between 48 diseases were inves-
tigated. The explanation for the difference in results
between our study and the Barendregt and Bonneux study
is straightforward: if more diseases are taken into account,
there is more comorbidity, especially if comorbidity
between all disease combinations is described. With a
higher prevalence of comorbidity, the method used to
adjust for comorbidity becomes more important.
A crucial assumption in this paper is that of independence
between diseases. Although this assumption may be vio-
lated in practice, it will not influence our conclusion that
adjustments for comorbidity are important in HALE cal-
culations. In fact, assuming independence probably
underestimates the amount of comorbidity since the
probability of getting different diseases is not independ-
ent due to clustering of diseases as a result of genetics, bio-
logical risk factors (e.g. blood pressure, cholesterol)
environmental factors (e.g. air pollution) and lifestyle
(e.g. smoking and drinking) [13,14].
Different methods to define disability weights for comor-
bidity can have important implications not only for the
estimation of HALE itself but also on applications of
HALE such as monitoring trends in health or as an aid in
priority setting. Even if the same methodology to adjust
for comorbidity is used consistently, the choice of the
adjustment method might influence the manner in which
HALE reacts to trends or interventions. For instance, when
using the maximum adjustment method eliminating dis-
eases with low disability weights has smaller or even no
impact on HALE compared to the multiplicative adjust-
ment method. Furthermore, both the maximum and mul-
tiplicative adjustment methods imply that in priority
setting, ceteris paribus, less priority should be given to
patients with more comorbidity. For example, improving
diabetes care in diabetes patients without coronary heart
disease results in a larger increase in average disability
than diabetes care in patients with coronary heart disease.
This latter example demonstrates that the choice for
comorbidity adjustment might also have implications for
equity trade-offs. Moreover, for the comparison of effects
of specific interventions targeted at groups with different
comorbidity prevalences (e.g. young and old), the choice
of adjustment method may have a different impact for dif-
ferent interventions, and thus may affect the conclusion.
The problems caused by comorbidity in HALE calcula-
tions are not present if self reported generic measures of
health such as the EQ-5D are used. [15-17] Then, patients
decide for themselves how the total disability that is
caused by all concurrent diseases influences their func-
tioning and quality of life. Therefore, empirical results of
studies using self reported generic measures could be used
to develop a more general theory as to how comorbidity
influences disability. For instance, a question that needs
to be answered is whether two comorbid diseases from
different "disease clusters" (such as a physically limiting
disease combined with a mental disease) leads to more
disability than two or more diseases from one "disease
cluster". Such a theory might be used to justify the choice
for a specific adjustment method in HALE calculations.
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Appendix: derivation of average disability 
weights for maximum adjustment method
The fraction of the population that gets the weight of dis-
ease d equals the prevalence rate of disease d minus the
fraction of the population that has disease d but also a dis-
ease with a higher disability weight. Assuming that the
diseases are ordered in terms of disability weights, e.g.
w1≥w2≥w3 .....................wn we can write this principle for
three diseases as:
H1 = p1
H2 = p2 *(1 - p1)
H3 = p3 *(1 - (p1 + p2 - p2 * p2))
Hd prevalence rate for which disease d has the highest disability
weight
pd prevalence rate of disease d
This can be rewritten to:
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H2 = (1 - H1) p2
H3 = (1 - H1 - H2) p3
Using this we can recursively define the prevalence rate
Hd:
The average disability weight can then be written as:
m average disability weight
wd disability weight of disease d
Additional material
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